Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:08 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
90,110
ILa
|
-1.23%
|
|
-0.98%
|
-1.42%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,046
|
1,599
|
1,468
|
3,334
|
2,719
|
1,949
|
Enterprise Value (EV)
1 |
5,384
|
4,929
|
4,916
|
6,795
|
5,175
|
3,935
|
P/E ratio
|
3.7
x
|
9.96
x
|
-8.4
x
|
37.6
x
|
2.83
x
|
7.07
x
|
Yield
|
-
|
-
|
-
|
-
|
2.92%
|
2.01%
|
Capitalization / Revenue
|
0.37
x
|
0.3
x
|
0.29
x
|
0.48
x
|
0.27
x
|
0.26
x
|
EV / Revenue
|
0.97
x
|
0.94
x
|
0.97
x
|
0.98
x
|
0.52
x
|
0.52
x
|
EV / EBITDA
|
4.84
x
|
4.51
x
|
6.04
x
|
4.33
x
|
1.31
x
|
2.45
x
|
EV / FCF
|
20.1
x
|
14.7
x
|
70.4
x
|
43.9
x
|
4.37
x
|
5.72
x
|
FCF Yield
|
4.98%
|
6.81%
|
1.42%
|
2.28%
|
22.9%
|
17.5%
|
Price to Book
|
1.47
x
|
1.03
x
|
1.05
x
|
2.17
x
|
1.11
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
7,698
|
7,698
|
7,698
|
7,698
|
7,698
|
7,702
|
Reference price
2 |
265.8
|
207.7
|
190.7
|
433.1
|
353.2
|
253.1
|
Announcement Date
|
3/19/19
|
4/7/20
|
3/18/21
|
3/24/22
|
3/16/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,556
|
5,271
|
5,043
|
6,955
|
10,015
|
7,536
|
EBITDA
1 |
1,113
|
1,093
|
814
|
1,570
|
3,956
|
1,603
|
EBIT
1 |
709
|
702
|
320
|
1,154
|
3,536
|
1,158
|
Operating Margin
|
12.76%
|
13.32%
|
6.35%
|
16.59%
|
35.31%
|
15.37%
|
Earnings before Tax (EBT)
1 |
1,291
|
566
|
-131
|
822
|
3,331
|
962
|
Net income
1 |
549
|
158
|
-173
|
88
|
953
|
273
|
Net margin
|
9.88%
|
3%
|
-3.43%
|
1.27%
|
9.52%
|
3.62%
|
EPS
2 |
71.86
|
20.85
|
-22.69
|
11.53
|
124.9
|
35.79
|
Free Cash Flow
1 |
268
|
335.6
|
69.88
|
154.9
|
1,185
|
687.9
|
FCF margin
|
4.82%
|
6.37%
|
1.39%
|
2.23%
|
11.83%
|
9.13%
|
FCF Conversion (EBITDA)
|
24.08%
|
30.71%
|
8.58%
|
9.86%
|
29.95%
|
42.91%
|
FCF Conversion (Net income)
|
48.82%
|
212.42%
|
-
|
175.99%
|
124.34%
|
251.97%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
10.33
|
5.086
|
Announcement Date
|
3/19/19
|
4/7/20
|
3/18/21
|
3/24/22
|
3/16/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,338
|
3,330
|
3,448
|
3,461
|
2,456
|
1,986
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.999
x
|
3.047
x
|
4.236
x
|
2.204
x
|
0.6208
x
|
1.239
x
|
Free Cash Flow
1 |
268
|
336
|
69.9
|
155
|
1,185
|
688
|
ROE (net income / shareholders' equity)
|
38.3%
|
11.2%
|
-4.08%
|
14%
|
42.7%
|
11.1%
|
ROA (Net income/ Total Assets)
|
4.32%
|
4.23%
|
1.84%
|
6.18%
|
17.4%
|
5.57%
|
Assets
1 |
12,696
|
3,733
|
-9,392
|
1,424
|
5,466
|
4,900
|
Book Value Per Share
2 |
181.0
|
201.0
|
182.0
|
200.0
|
319.0
|
360.0
|
Cash Flow per Share
2 |
25.90
|
35.60
|
80.30
|
66.00
|
98.90
|
69.70
|
Capex
1 |
572
|
576
|
627
|
611
|
747
|
780
|
Capex / Sales
|
10.3%
|
10.93%
|
12.43%
|
8.79%
|
7.46%
|
10.35%
|
Announcement Date
|
3/19/19
|
4/7/20
|
3/18/21
|
3/24/22
|
3/16/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| -1.42% | 1.79B | | +4.41% | 74.89B | | +0.56% | 46.52B | | -3.94% | 30.82B | | +11.27% | 18.19B | | -9.54% | 11.54B | | +8.37% | 11.24B | | -7.33% | 9.73B | | +5.82% | 9.4B | | +6.33% | 9.37B |
Diversified Chemicals
|